The Community Guide

- gsearch

Search Results

Narrow Results:

2022 1
2021 1

Journal Article 2

1 - 2 of 2 Results

Refine Results

Refine Results:

Epidemiology and risk factors related to severity of clinical manifestations of COVID-19 in outpatients: A retrospective study in Haiti

CITE Title : Epidemiology and risk factors related to severity of clinical manifestations of COVID-19 in outpatients: A retrospective study in Haiti Personal Author(s) : Lucien, Mentor Ali Ber;Pierre, Katilla;Jean-Denis, Gladzdin;Rigodon, Jonas;Worrell, Caitlin M.;Couture, Alexia;Flynn, Aspen;Calderon, Mauricio Cerpa;Codina, Luis Felipe;Vicari, Andrea S.;Marseille, Samson;Jean Baptiste, Koama T.;Fouche, Bernadette;Joseph, Gerard;Journel, Ito;Rendel, Kenold;Grant-Greene, Yoran;Jean-Charles, Nadia P.;Lafontant, Donald;Amouzou, Senou;Pierre, Wilnique;Clement, Marie Greta Roy;Juin, Stanley;Boncy, Jacques;Dely, Patrick; Published Date : 9 21 2022 Source : PLoS One. 17(9) URL : https://stacks.cdc.gov/view/cdc/121643 Lucien, Mentor Ali Ber et al. (2022). Epidemiology and risk factors related to severity of clinical manifestations of COVID-19 in outpatients: A retrospective study in Haiti. 17(9). Lucien, Mentor Ali Ber et al. "Epidemiology and risk factors related to severity of clinical manifestations of COVID-19 in outpatients: A retrospective study in Haiti" 17, no. 9 (2022) Lucien, Mentor Ali Ber et al. "Epidemiology and risk factors related to severity of clinical manifestations of COVID-19 in outpatients: A retrospective study in Haiti" vol. 17, no. 9, 2022 Export RIS Citation Information.

:

Lucien, Mentor Ali Ber ;

Pierre, Katilla

9 21 2022 | PLoS One. 17(9)

:

BackgroundHaiti’s first COVID-19 cases were confirmed on March 18, 2020, and subsequently spread throughout the country. The objective of this study...
EFFECTIVENESS OF MONOVALENT ROTAVIRUS VACCINE AGAINST HOSPITALIZATIONS DUE TO ALL ROTAVIRUS AND EQUINE-LIKE G3P[8] GENOTYPES IN HAITI 2014–2019

CITE Title : EFFECTIVENESS OF MONOVALENT ROTAVIRUS VACCINE AGAINST HOSPITALIZATIONS DUE TO ALL ROTAVIRUS AND EQUINE-LIKE G3P[8] GENOTYPES IN HAITI 2014–2019 Personal Author(s) : Burnett, Eleanor;Juin, Stanley;Esona, Mathew D.;Desormeaux, Anne Marie;Aliabadi, Negar;Pierre, Manise;Andre-Alboth, Jocelyn;Leshem, Eyal;Etheart, Melissa D.;Patel, Roopal;Dely, Patrick;Fitter, David;Jean-Denis, Gladzdin;Kalou, Mireille;Katz, Mark A.;Bowen, Michael D.;Grant-Greene, Yoran;Boncy, Jacques;Parashar, Umesh D.;Joseph, Gerard A.;Tate, Jacqueline E.; Published Date : 7 22 2021;7-22-; Source : Vaccine. 39(32):4458-4462 URL : https://stacks.cdc.gov/view/cdc/110136 Burnett, Eleanor et al. (2021). EFFECTIVENESS OF MONOVALENT ROTAVIRUS VACCINE AGAINST HOSPITALIZATIONS DUE TO ALL ROTAVIRUS AND EQUINE-LIKE G3P[8] GENOTYPES IN HAITI 2014–2019. 39(32). Burnett, Eleanor et al. "EFFECTIVENESS OF MONOVALENT ROTAVIRUS VACCINE AGAINST HOSPITALIZATIONS DUE TO ALL ROTAVIRUS AND EQUINE-LIKE G3P[8] GENOTYPES IN HAITI 2014–2019" 39, no. 32 (2021) Burnett, Eleanor et al. "EFFECTIVENESS OF MONOVALENT ROTAVIRUS VACCINE AGAINST HOSPITALIZATIONS DUE TO ALL ROTAVIRUS AND EQUINE-LIKE G3P[8] GENOTYPES IN HAITI 2014–2019" vol. 39, no. 32, 2021 Export RIS Citation Information.

:

Burnett, Eleanor ;

Juin, Stanley

7 22 2021 | Vaccine. 39(32):4458-4462

:

Background:Rotavirus vaccines are effective in preventing severe rotavirus. Haiti introduced 2-dose monovalent (G1P[8]) rotavirus vaccine recommended ...